Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000350124

Medchemexpress LLC Thalidomide-Propargyne-PEG2-COOH | 2797619-65-7 | 98.7% | 428.39 | 25 MG
SDP

Catalog No. 5000350124
Encompass_Preferred

Thalidomide-Propargyne-PEG2-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the thalidomide based cereblon ligand and a linker used in PROTAC technology. It is a click chemistry reagent, containing an alkyne group, and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing azide groups.

  • Synthesized E3 ligase ligand-linker conjugate.
  • Incorporates thalidomide based cereblon ligand.
  • Uses a linker in PROTAC technology.
  • Click chemistry reagent.
  • Contains an alkyne group.
  • Undergoes copper-catalyzed azide-alkyne cycloaddition (CuAAc).

Catalog No. 50-003-50124 Supplier Medchemexpress LLC Supplier No. 25MGHY138777
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Thalidomide-Propargyne-PEG2-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the thalidomide based cereblon ligand and a linker used in PROTAC technology. It is a click chemistry reagent, containing an alkyne group, and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing azide groups.

  • Synthesized E3 ligase ligand-linker conjugate.
  • Incorporates thalidomide based cereblon ligand.
  • Uses a linker in PROTAC technology.
  • Click chemistry reagent.
  • Contains an alkyne group.
  • Undergoes copper-catalyzed azide-alkyne cycloaddition (CuAAc).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.